MEEDER ASSET MANAGEMENT INC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,0000.0%19
+46.2%
0.00%
Q2 2022$1,0000.0%13
+44.4%
0.00%
Q1 2022$1,0009
+800.0%
0.00%
Q3 2021$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q1 2020$135,000
-70.9%
3,998
-61.0%
0.01%
-64.3%
Q4 2019$464,000
+2477.8%
10,247
+1945.3%
0.03%
+2700.0%
Q3 2019$18,000
-93.3%
501
-91.9%
0.00%
-94.7%
Q2 2019$268,000
+13.1%
6,159
-1.0%
0.02%0.0%
Q1 2019$237,000
+19.7%
6,223
+35.2%
0.02%
+5.6%
Q4 2018$198,000
+3200.0%
4,603
+3735.8%
0.02%
Q3 2018$6,000
-99.8%
120
+22.4%
0.00%
Q2 2018$3,141,000
+104600.0%
980.0%0.00%
Q1 2018$3,0000.0%98
+66.1%
0.00%
Q2 2017$3,000
-76.9%
59
-79.8%
0.00%
-100.0%
Q1 2017$13,000
-31.6%
292
-50.5%
0.00%
-50.0%
Q4 2016$19,000
-9.5%
590
+18.0%
0.00%0.0%
Q3 2015$21,000
-40.0%
5000.0%0.00%
-50.0%
Q2 2015$35,000
-20.5%
5000.0%0.00%
-20.0%
Q1 2015$44,0000.0%5000.0%0.01%
-16.7%
Q4 2014$44,000
-8.3%
5000.0%0.01%
-14.3%
Q3 2014$48,000
-25.0%
500
-28.6%
0.01%
-22.2%
Q2 2014$64,000
+30.6%
7000.0%0.01%
+12.5%
Q1 2014$49,000
+22.5%
7000.0%0.01%
+14.3%
Q4 2013$40,000
+17.6%
7000.0%0.01%
+16.7%
Q3 2013$34,000
+70.0%
7000.0%0.01%
+50.0%
Q2 2013$20,0007000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders